In 2017, the United States Supreme Court held in Bristol-Myers Squibb Co. v. Superior Court of California (BMS) that the exercise of personal jurisdiction by a California state court over the claims of non-California plaintiffs did not comport with due process because the court lacked personal jurisdiction to adjudicate those claims against the defendant.